Probiotics for Prevention of Neratinib-Induced Diarrhea in Breast Cancer Patients

NCT06892093 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

308

Enrollment

OTHER

Sponsor class

Conditions

HER2-positive Breast Cancer
Diarrhea Caused by Drug
Neratinib

Interventions

DIETARY_SUPPLEMENT: Probiotics
DIETARY_SUPPLEMENT: Placebo
DRUG: Loperamide

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Collaborators

[object Object]